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Malnutrition and inflammation in peritoneal dialysis patients.
Background. Malnutrition, cardiovascular disease, and height-
ened inflammation are highly prevalent in dialysis patients,
and major contributors to morbidity and mortality. We have
investigated the inter-relationship between malnutrition and
inflammation, and their impact on morbidity and mortality in
peritoneal dialysis (PD) patients.
Method. We enrolled 63 PD patients beginning in November
2000, and measured C-reactive protein (CRP) and various nu-
tritional markers, including prealbumin.
Results. CRP level was elevated in 29% of the PD patients.
Diabetics had higher CRP than non-diabetics (24 vs. 9.3 mg/L,
P  0.016). Patients who were hospitalized during the study
had higher enrollment CRP (16 vs. 12.5 mg/L, P  0.05) and
lower enrollment albumin (3.5 vs. 3.9 g/dL, P  0.002), blood
urea nitrogen (BUN) (40 vs. 49 mg/dL, P 0.034), and protein
catabolic rate (nPCR) (0.88 vs. 1.0 g/kg/day, P  0.02) than
those who were not hospitalized. Enrollment level of CRP was
inversely correlated with nutritional markers prealbumin (r 
0.5, P  0.0001) and creatinine (r 0.35, P  0.01). After
adjusting for age, race, gender, diabetes, and CRP level, preal-
bumin continued to correlate with other nutritional markers.
There was a trend toward association of elevated CRP with
all-cause mortality in PD patients.
Conclusion. It is useful to incorporate prealbumin and CRP
in the regular assessment of PD patients, whose survival may
be improved by better management of malnutrition and in-
flammation.
Protein and calorie malnutrition is highly prevalent
among dialysis patients. The strong association between
malnutrition and outcome in this population is now well
established [1]. The nutritional status of dialysis patients
can be determined by biochemical assays, anthropome-
try, protein catabolic rate (nPCR), and body composition
methods. Over the past decade, various nutritional pa-
rameters have emerged as powerful predictors of mortal-
ity in dialysis patients. Measures of visceral (serum albu-
min and cholesterol) and somatic protein (creatinine)
stores have been well-described predictors of survival in
hemodialysis (HD) and peritoneal dialysis (PD) patients
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[2–4]. Among the newer indices of nutrition, serum pre-
albumin has received increasing attention. Due to its
rapid turnover rate, short half-life, high tryptophan con-
tent, and small pool size, prealbumin is a highly sensitive
marker of nutritional status [5]. We have reported the
importance of serum prealbumin in predicting nutri-
tional status and mortality in both HD and PD patients
[6–8]. Chertow et al [9] confirmed that prealbumin pro-
vides prognostic value in HD patients, independent of
albumin and other established predictors of mortality.
Recently, the inter-relationship between malnutrition
and inflammation has received considerable attention. A
strong association between protein energy malnutrition
(PEM) and inflammation has been shown in dialysis pa-
tients [10]. Inflammation is a common feature in end-
stage renal disease (ESRD) [11], and is an important
contributor to the development of hypoalbuminemia in
HD patients, in addition to malnutrition and inadequate
dialysis [12]. The association between nutritional mark-
ers and inflammatory markers such as C-reactive protein
(CRP), however, has not been studied critically in PD
patients. In one study on PD patients, serum albumin
concentration was inversely correlated with serum con-
centration of CRP [13]. Acute phase proteins such as
CRP and serum amyloid are well-known indicators of
inflammation, which, as in the general population, have
been linked to cardiovascular risk and mortality in HD
patients [14]. Cardiovascular disease (CVD) is the lead-
ing cause of mortality in dialysis patients [15], and both
PEM and inflammation are associated with increased
morbidity and mortality, including the risk of cardiovas-
cular death. Several investigators have reported that an
increased level of CRP is a strong predictor of all-cause
and of cardiovascular mortality in HD patients [16–18].
The prognostic importance of CRP has not been studied
in detail in PD patients [19].
Prealbumin, a negative acute-phase protein, is an im-
portant marker of nutrition in the dialysis population
[8]. The predictive power of marker proteins may be
influenced by the inflammatory state, which is episodic
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Table 1. Enrollment data of PD patients by diabetic status
Nondiabetic Diabetic
Variable (N  39) (N  24) P
C-reactive protein mg/L 9.329.36 24.2635.7 0.016
Prealbumin mg/dL 42.511.6 35.210.3 0.012
Albumin g/dL 3.70.57 3.510.36 0.15
Creatinine mg/dL 123.90 8.72.51 0.0001
BUN mg/dL 44.816.1 39.713.3 0.19
Total cholesterol mg/dL 18345.6 23281 0.004
nPCR g/kg/day 0.920.22 0.910.22 0.17
Abbreviations are: BUN, blood urea nitrogen; nPCR, protein catabolic rate;
PD, peritoneal dialysis.
in dialysis patients. Changes in acute-phase proteins,
including prealbumin, can reflect the presence of an on-
going or resolving inflammatory condition that may in-
fluence the patient’s nutritional state and, ultimately,
mortality risk. Most of the work linking malnutrition and
inflammation has been done in HD patients using CRP
and other acute-phase proteins with serum albumin.
There is a paucity of literature concerning the association
between inflammation and malnutrition, as indicated by
prealbumin and little data available in PD patients. In
the present study, we evaluate the inter-relationship be-
tween nutritional status and inflammation, and their im-
pact on morbidity and mortality in PD patients.
METHODS
Patients
Sixty-three PD patients at the Avram Center for Kid-
ney Diseases were enrolled in the study beginning in
November 2000. On enrollment, demographic and clini-
cal data collected included age, race, gender, diabetic
status, etiology of ESRD, total months on dialysis at
enrollment, history of atherosclerotic heart disease, and
number of hospitalizations. Protein catabolic rate nor-
malized to body weight (nPCR) was measured by Baxter
PD Adequest, version 1.4, a computer-based kinetic
modeling program for peritoneal dialysis (Baxter Health-
care Corporation, McGaw Park, IL, USA). Patients were
followed until April 2003.
Laboratory analysis
Non-fasting blood samples were collected at a routine
monthly visit and a multiphasic biochemistry screen in-
cluding albumin, creatinine, blood urea nitrogen (BUN),
total cholesterol, prealbumin, and CRP were performed.
Albumin concentration was determined by the bromo-
cresol green method. Prealbumin and CRP were mea-
sured by immunoturbidimetric method (Spectra East,
Rockleigh, NJ, USA). CRP values less than 15 mg/L
were considered normal. Serial measurements of CRP,
prealbumin, albumin, creatinine, BUN, and nPCR were
recorded.
Table 2. Enrollment data of PD patients by hospitalization
Hospitalized Not hospitalized
Variable (N  44) (N  19) P
C-reactive protein mg/L 16.124 12.525 0.05
Prealbumin mg/dL 39.012 4210 0.29
Albumin g/dL 3.510.51 3.890.39 0.002
Creatinine mg/dL 10.43.5 11.54.3 0.33
BUN mg/dL 4015 4915 0.034
Total cholesterol mg/dL 21075 18632 0.19
nPCR g/kg/day 0.880.24 1.00.15 0.02
Abbreviations are: BUN, blood urea nitrogen; nPCR, normal protein catabolic
rate; PD, peritoneal dialysis.
Statistical analysis
Continuous variables were reported as mean  SD.
For selected comparisons between group means, para-
metric (t test) or non-parametric (Mann-Whitney test)
were used. Correlations were reported as either the
Pearson correlation coefficient or the Spearman rank
correlation coefficient. Both non-transformed and loga-
rithm-transformed CRP values were used to examine
correlations. Patient survival was analyzed with death
considered as the final event. Transfer to another center
or switch of dialysis modality was regarded as censored
information. Observed survival of PD patients was com-
puted by Kaplan-Meier method [20]. Log-rank testing
was used to compare survival curves. Calculations were
performed using SPSS for Windows 10.0.1 (SPSS Inc.,
Chicago, IL, USA).
RESULTS
Demographics and patient characteristics
The mean age of PD patients was 55 years. Thirty-
eight percent of the patients were diabetic and 62% were
female. The mean time on PD at enrollment was 46 
45 months. The causes of ESRD were as follows: 35%
diabetes, 33% hypertension, 8% glomerulonephritis, 3%
polycystic kidney disease, 2% obstruction, 6% HIV, and
13% other/unknown. The mean and maximum follow-
ups were 1.18 and 1.83 years, respectively.
Laboratory data
At enrollment, the mean serum prealbumin and CRP
levels were 40  12 mg/dL and 15  24 mg/L, respec-
tively. The mean enrollment albumin was 3.62  0.51
g/dL, creatinine was 10.7  3.8 mg/dL, total cholesterol
was 203  65 mg/dL, and BUN was 43  15 mg/dL.
Twenty-nine percent of the patients had enrollment CRP
levels greater than 15 mg/L, indicating a heightened in-
flammatory state. Enrollment prealbumin (42.5 vs. 35.2
mg/dL, P  0.012) and creatinine (12 vs. 8.7 mg/dL, P 
0.0001) were significantly higher, and CRP (9.3 vs. 24
mg/L, P 0.016) was significantly lower in non-diabetics
compared to diabetic patients (Table 1). Patients with a
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Fig. 1. Relationship between log C-reactive protein (CRP) and preal-
bumin in 63 peritoneal dialysis PD patients (r  0.5, P  0.0001).
Table 3. Correlation coefficients of enrollment prealbumin and
C-reactive protein with biochemical markers (N  63)
C-reactive
Variable Prealbumin protein
Albumin g/dL 0.56c 0.2
Total cholesterol mg/dL 0.18 0.004
Creatinine mg/dL 0.48c 0.35b
BUN mg/dL 0.43c 0.17
nPCR g/kg/day 0.28a 0.17
WBC million/lL 0.14 0.33b
Abbreviations are: BUN, blood urea nitrogen; nPCR, normal protein catabolic
rate; WBC, white blood cells.
aP  0.05
bP  0.01
cP  0.0001
history of hypertension had significantly higher CRP lev-
els compared to those without hypertension (15.4 vs. 6.5
mg/L, P  0.029). Enrollment albumin (3.5 vs. 3.9 g/dL,
P  0.002), BUN (40 vs. 49 mg/dL, P  0.034), and
nPCR (0.88 vs. 1.0 g/kg/day, P  0.02) were lower, and
CRP (16 vs. 12.5 mg/L, P  0.05) was higher in patients
hospitalized during the study compared to those who
were not hospitalized (Table 2). There was no significant
difference in the concentration of CRP between patients
with heart disease and those without heart disease (18.5
vs. 13.2 mg/L, P  0.88). Serum prealbumin (33.2 vs.
42.4 mg/dL, P 0.01) and creatinine (8.9 vs. 11.5 mg/dL,
P  0.05) were significantly lower in patients with CRP
greater than 15 mg/L compared to those with CRP less
than 15 mg/L.
Correlations
Enrollment serum prealbumin concentrations were in-
versely correlated with log CRP (r  0.5, P  0.0001)
(Fig. 1), and mean serum prealbumin measured serially
was inversely correlated with mean CRP (r0.36, P
0.004). The correlations of prealbumin and CRP with
serum nutritional markers are shown in Table 3. Serum
Table 4. Correlations of prealbumin with nutritional markers
in patients grouped by C-reactive protein
Variable CRP 10 mg/L CRP 10 mg/L
Albumin g/dL 0.56c 0.45a
Creatinine mg/dL 0.45b 0.28
BUN mg/dL 0.48b 0.44a
Abbreviations are: BUN, blood urea nitrogen; CRP, C-reactive protein.
aP  0.05
bP  0.01
cP  0.0001
Fig. 2. Graph showing the course of C-reactive protein (CRP) and
prealbumin in peritoneal dialysis (PD) patients during the study period.
prealbumin was directly correlated with routine nutri-
tional markers such as albumin (r  0.56, P  0.0001),
creatinine (r  0.48, P  0.0001), BUN (r  0.43, P 
0.0001), and nPCR (r 0.28, P 0.05). CRP was directly
correlated with peripheral white blood cell (WBC) count
(r 0.33, P 0.01), and inversely correlated with creati-
nine (r  0.35, P  0.01). Using partial correlations,
and adjusting for age, race, gender, diabetic status, HIV
status, and CRP, prealbumin continued to correlate with
nutritional markers such as albumin (r 0.39, P 0.004),
creatinine (r  0.32, P  0.02), BUN (r  0.37, P 
0.008), and nPCR (r  0.3, P  0.03). In multivariate
regression analysis, both enrollment (beta coefficient 
0.30, P 0.03) and mean serum prealbumin measured
serially (beta coefficient  0.41, P  0.002) were in-
versely correlated with CRP. Enrollment age (r  0.25,
P  0.047) and presence of diabetes (beta coefficient 
0.30, P 0.016) were directly and significantly associated
with mean CRP (r  0.25, P  0.047). Gender and race
were not significant predictors of CRP in PD patients.
Correlations of prealbumin with nutritional markers and
CRP were examined in patients grouped by CRP level.
The inverse association between prealbumin and CRP
was weaker in patients with lower CRP concentration.
In patients with CRP less than 10 mg/L, there was no
correlation between prealbumin and CRP, while preal-
bumin was more strongly correlated with nutritional
markers (Table 4). Figure 2 displays the serum prealbu-
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Fig. 3. Kaplan-Meier estimates of observed survival during follow-up
with regard to all-cause mortality in peritoneal dialysis (PD) patients
stratified by enrollment C-reactive protein (CRP). P  0.46
min and CRP profiles measured serially over the course
of the study. Each data point represents the average
value of all the patients. Each increase or decrease in
CRP concentration was associated with a reciprocal de-
crease or increase in prealbumin.
Survival
During the study period, 12 (19%) patients died. There
was no significant difference in enrollment or in mean
CRP level between the patients who died and those who
survived. Cumulative survival of patients with enroll-
ment CRP 15 mg/L was better than those with CRP
15 mg/L, but the difference did not reach statistical
significance (Fig. 3).
DISCUSSION
The results of this study confirm the relationship be-
tween indicators of malnutrition and measures of in-
flammation in PD patients. It is well established that
serum levels of nutritional markers such as albumin,
creatinine, and prealbumin are decreased in malnour-
ished dialysis patients, and that lower levels of these
nutritional markers are associated with increased mortal-
ity in these patients [2, 7, 8, 21–24]. Several of these
serum markers are also negative acute-phase proteins
that are decreased in inflammatory states. Serum preal-
bumin is such a negative acute-phase reactant protein,
as demonstrated by the inverse correlation of prealbu-
min with CRP in this study. We have previously reported
the association of lower levels of prealbumin with in-
creased mortality in dialysis patients, including patients
maintained on PD. This increased mortality risk may be
due to malnutrition, to the underlying cause of height-
ened inflammation, or to a combination of the two. In
this study, we examined the relationship of prealbumin to
CRP levels and other nutritional markers in PD patients
grouped by CRP level. We found that in PD patients
without heightened inflammatory state (CRP 10
mg/L), prealbumin was highly correlated with various
serum nutritional markers (Table 4). This relationship
was confirmed by the partial correlation analysis; preal-
bumin was strongly correlated with other nutritional
markers after controlling for demographics and CRP,
and suggested that the CRP level may be utilized to
determine the cause of low serum prealbumin, malnutri-
tion, or heightened inflammation. There are two types
of malnutrition in dialysis patients, one associated with
or due to the uremic syndrome, and the other with co-
morbid conditions and inflammation, as suggested by
Stenvinkel et al [25]. In addition to its relation with
prealbumin, we observed an inverse correlation between
CRP and serum creatinine. Serum creatinine is a marker
of somatic protein stores, but unlike prealbumin, serum
creatinine is not a negative acute-phase protein. This
relationship between CRP and creatinine implies a link
between malnutrition and inflammatory state in PD pa-
tients.
Serum albumin, also a negative acute-phase protein,
is the most widely used nutritional marker in dialysis
patients. There are conflicting reports in the literature
regarding the association between CRP and albumin in
dialysis patients. Qureshi et al [26] found an inverse
association of CRP with albumin. In addition, lower se-
rum albumin has been reported in continuous ambula-
tory peritoneal dialysis (CAPD) patients with persis-
tently elevated CRP level [27]. In the present study,
however, the correlation of albumin with CRP did not
reach statistical significance (r  0.22, P  0.078) (Ta-
ble 3). This is in agreement with another published report
that found no significant difference in serum albumin
level between patients with normal and elevated levels
of CRP [19].
Elevated levels of CRP predict cardiovascular events
in general population [28], as well as in HD patients [14].
CRP is a strong predictor of cardiovascular and of all-
cause mortality in HD patients [18]. Persistent elevations
of CRP level have been associated with ischemic heart
disease in CAPD patients [27], and chronic inflammation
has been shown to independently contribute to an in-
creased incidence of cardiovascular events in PD patients
[29]. We, however, did not find a difference in CRP level
between patients with or without a history of atheroscle-
rotic heart disease.
There have been conflicting reports in the literature
regarding an association between CRP and mortality
risk. We found a trend toward association between in-
creased CRP level and higher all-cause mortality in PD
patients, but the difference did not reach statistical sig-
nificance (Fig. 3). Herzig et al [19] also reported that
CRP was not predictive of all cause mortality in PD
patients. Others, however, have found an association
between elevated CRP and risk of death in PD patients
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[29]. Cardiovascular disease commonly occurs in patients
with hypertension and diabetes. Our finding that higher
CRP level is associated with the presence of diabetes
and hypertension in PD patients has been recently re-
ported in the general population [28]. Kim et al [27] have
also reported a greater tendency of CAPD patients with
diabetic nephropathy to have persistently elevated CRP
compared to those who did not.
CONCLUSION
CRP level was elevated in a substantial minority of PD
patients. Diabetics and patients who were hospitalized
during the study had higher levels of CRP and lower
levels of nutritional indices. CRP was inversely corre-
lated with nutritional markers, including serum creati-
nine. In patients with CRP values within the normal
range, the correlation of prealbumin with CRP was weak,
but prealbumin remained highly correlated with other
nutritional markers. There was a trend toward associa-
tion of elevated CRP with all-cause mortality in PD
patients.
Our study presents evidence for an inter-relationship
between malnutrition and inflammation in PD patients.
Serum prealbumin, although a negative acute-phase pro-
tein, predicts nutritional status independent of inflam-
matory state. Regular measurement of serum prealbumin
and CRP may enhance the comprehensive assessment of
overall health status in PD patients. Identification and
management of malnutrition and inflammation should im-
prove survival in our patients.
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